Azitra (AZTR) vs Curanex Pharmaceuticals (CURX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Azitra is the larger company by market cap ($8.0 million vs $7.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AZTR | CURX |
|---|---|---|
| Share price | $0.132 | $4.76 |
| Market cap | $8.00M | $7.46M |
| 1-day change | 0.00% | -0.94% |
| EPS (TTM) | $-0.28 | $-7.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.09 | $16.94 |
| 52-week low | $0.10 | $3.58 |
| Distance from 52-week high | -87.89% | -71.90% |
| Analyst consensus | buy | — |
| Avg. price target upside | +407.58% | — |
| Average volume | 1.68M | 19.85K |
| Shares outstanding | 60.60M | 1.57M |
| Employees | 13 | 6 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Azitra
AZTR stock →Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S.
Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees
About Curanex Pharmaceuticals
CURX stock →Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
AZTR vs CURX FAQ
Which is bigger, Azitra or Curanex Pharmaceuticals?
Azitra (AZTR) is larger, with a market capitalization of $8.00M compared with $7.46M for Curanex Pharmaceuticals (CURX).
Are Azitra and Curanex Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.